Unicycive Therapeutics Revenue and Competitors
Estimated Revenue & Valuation
- Unicycive Therapeutics's estimated annual revenue is currently $4.5M per year.
- Unicycive Therapeutics's estimated revenue per employee is $155,000
Employee Data
- Unicycive Therapeutics has 29 Employees.
- Unicycive Therapeutics grew their employee count by 26% last year.
Unicycive Therapeutics's People
Name | Title | Email/Phone |
---|---|---|
1 | Founder & CEO | Reveal Email/Phone |
2 | Founder and CEO | Reveal Email/Phone |
3 | Chief Financial Officer | Reveal Email/Phone |
4 | EVP, Pharmaceutical & Business Operations, Unicycive Therapeutics, Inc. | Reveal Email/Phone |
5 | EVP, Corporate Strategy | Reveal Email/Phone |
6 | VP, Preclinical R&D | Reveal Email/Phone |
7 | VP, People and Culture | Reveal Email/Phone |
8 | VP, Scientific Affairs | Reveal Email/Phone |
9 | VP, Pre-clinical Pharmacology | Reveal Email/Phone |
10 | Executive Director - Global Marketing & New Product Planning | Reveal Email/Phone |
Unicycive Therapeutics Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $5.4M | 70 | -8% | $53M | N/A |
#2 | $32.4M | 167 | -26% | $110M | N/A |
#3 | $0.9M | 6 | 0% | N/A | N/A |
#4 | $2.8M | 18 | 13% | N/A | N/A |
#5 | $0.8M | 5 | -50% | N/A | N/A |
#6 | $0.8M | 10 | 0% | N/A | N/A |
#7 | $14M | 90 | -12% | N/A | N/A |
#8 | $0.4M | 336 | 10% | $236.7M | N/A |
#9 | $4.8M | 62 | -74% | $160M | N/A |
#10 | $3.7M | 24 | -8% | N/A | N/A |
What Is Unicycive Therapeutics?
Unicycive Therapeutics is passionate about treating kidney diseases with significant unmet medical needs.
keywords:N/AN/A
Total Funding
29
Number of Employees
$4.5M
Revenue (est)
26%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $2.9M | 29 | 7% | N/A |
#2 | $5.8M | 29 | -15% | N/A |
#3 | $4.3M | 29 | 21% | N/A |
#4 | $2.3M | 29 | 45% | $20M |
#5 | $2M | 29 | -15% | $40.6M |